Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Reza Dana, M.D.

Co-Author

This page shows the publications co-authored by Reza Dana and Sunil Chauhan.
Connection Strength

13.026
  1. PTK7+ Mononuclear Cells Express VEGFR2 and Contribute to Vascular Stabilization by Upregulating Angiopoietin-1. Arterioscler Thromb Vasc Biol. 2015 Jul; 35(7):1606-15.
    View in: PubMed
    Score: 0.651
  2. Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity. J Clin Cell Immunol. 2014; 5.
    View in: PubMed
    Score: 0.592
  3. CCL-21 conditioned regulatory T cells induce allotolerance through enhanced homing to lymphoid tissue. J Immunol. 2014 Jan 15; 192(2):817-23.
    View in: PubMed
    Score: 0.590
  4. A novel pro-lymphangiogenic function for Th17/IL-17. Blood. 2011 Oct 27; 118(17):4630-4.
    View in: PubMed
    Score: 0.504
  5. Role of Th17 cells in the immunopathogenesis of dry eye disease. Mucosal Immunol. 2009 Jul; 2(4):375-6.
    View in: PubMed
    Score: 0.433
  6. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol. 2009 Feb 01; 182(3):1247-52.
    View in: PubMed
    Score: 0.421
  7. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol. 2009 Jan 01; 182(1):148-53.
    View in: PubMed
    Score: 0.419
  8. Pigment Epithelium-Derived Factor Enhances the Suppressive Phenotype of Regulatory T Cells in a Murine Model of Dry Eye Disease. Am J Pathol. 2021 04; 191(4):720-729.
    View in: PubMed
    Score: 0.241
  9. Growth factor-eluting hydrogels for management of corneal defects. Mater Sci Eng C Mater Biol Appl. 2021 Jan; 120:111790.
    View in: PubMed
    Score: 0.239
  10. Restoration of Regulatory T-Cell Function in Dry Eye Disease by Antagonizing Substance P/Neurokinin-1 Receptor. Am J Pathol. 2020 09; 190(9):1859-1866.
    View in: PubMed
    Score: 0.231
  11. Pigment Epithelium-derived Factor secreted by corneal epithelial cells regulates dendritic cell maturation in dry eye disease. Ocul Surf. 2020 07; 18(3):460-469.
    View in: PubMed
    Score: 0.230
  12. The functions of IL-23 and IL-2 on driving autoimmune effector T-helper 17 cells into the memory pool in dry eye disease. Mucosal Immunol. 2021 01; 14(1):177-186.
    View in: PubMed
    Score: 0.229
  13. Aged Mice Exhibit Severe Exacerbations of Dry Eye Disease with an Amplified Memory Th17 Cell Response. Am J Pathol. 2020 07; 190(7):1474-1482.
    View in: PubMed
    Score: 0.229
  14. Regulatory T cells promote corneal endothelial cell survival following transplantation via interleukin-10. Am J Transplant. 2020 02; 20(2):389-398.
    View in: PubMed
    Score: 0.222
  15. The purinergic receptor antagonist oxidized adenosine triphosphate suppresses immune-mediated corneal allograft rejection. Sci Rep. 2019 06 13; 9(1):8617.
    View in: PubMed
    Score: 0.216
  16. Local Delivery of Regulatory T Cells Promotes Corneal Allograft Survival. Transplantation. 2019 01; 103(1):182-190.
    View in: PubMed
    Score: 0.209
  17. The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease. Ocul Surf. 2018 10; 16(4):470-477.
    View in: PubMed
    Score: 0.203
  18. Interleukin-6 neutralization prolongs corneal allograft survival. Curr Trends Immunol. 2018; 19:105-113.
    View in: PubMed
    Score: 0.195
  19. When Clarity Is Crucial: Regulating Ocular Surface Immunity. Trends Immunol. 2018 04; 39(4):288-301.
    View in: PubMed
    Score: 0.195
  20. IFN-?-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity. J Immunol. 2017 08 01; 199(3):1163-1169.
    View in: PubMed
    Score: 0.188
  21. Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation. Sci Rep. 2017 04 20; 7(1):971.
    View in: PubMed
    Score: 0.186
  22. Proangiogenic Function of T Cells in Corneal Transplantation. Transplantation. 2017 04; 101(4):778-785.
    View in: PubMed
    Score: 0.185
  23. T Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration. Invest Ophthalmol Vis Sci. 2017 02 01; 58(2):1330-1336.
    View in: PubMed
    Score: 0.183
  24. Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity. J Autoimmun. 2017 02; 77:96-103.
    View in: PubMed
    Score: 0.181
  25. IL-17 Augments B Cell Activation in Ocular Surface Autoimmunity. J Immunol. 2016 11 01; 197(9):3464-3470.
    View in: PubMed
    Score: 0.179
  26. Ageing and ocular surface immunity. Br J Ophthalmol. 2017 Jan; 101(1):1-5.
    View in: PubMed
    Score: 0.176
  27. Alloimmunity and Tolerance in Corneal Transplantation. J Immunol. 2016 05 15; 196(10):3983-91.
    View in: PubMed
    Score: 0.174
  28. E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation. Transplantation. 2016 Apr; 100(4):772-80.
    View in: PubMed
    Score: 0.173
  29. Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis. Invest Ophthalmol Vis Sci. 2016 Mar; 57(3):1457-67.
    View in: PubMed
    Score: 0.172
  30. In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation. Transplantation. 2016 Mar; 100(3):525-32.
    View in: PubMed
    Score: 0.172
  31. VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation. Transplantation. 2015 Apr; 99(4):678-86.
    View in: PubMed
    Score: 0.161
  32. The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. Invest Ophthalmol Vis Sci. 2014 Aug 21; 55(9):5944-51.
    View in: PubMed
    Score: 0.155
  33. CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease. Invest Ophthalmol Vis Sci. 2014 Aug 19; 55(9):5871-7.
    View in: PubMed
    Score: 0.155
  34. Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival. Graefes Arch Clin Exp Ophthalmol. 2014 Nov; 252(11):1755-62.
    View in: PubMed
    Score: 0.154
  35. A novel pro-angiogenic function for interferon-?-secreting natural killer cells. Invest Ophthalmol Vis Sci. 2014 May 02; 55(5):2885-92.
    View in: PubMed
    Score: 0.151
  36. Effects of topical Janus kinase inhibition on ocular surface inflammation and immunity. Cornea. 2014 Feb; 33(2):177-83.
    View in: PubMed
    Score: 0.149
  37. Expression of the chemokine decoy receptor D6 mediates dendritic cell function and promotes corneal allograft rejection. Mol Vis. 2013; 19:2517-25.
    View in: PubMed
    Score: 0.148
  38. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Invest Ophthalmol Vis Sci. 2013 Jun 12; 54(6):4081-91.
    View in: PubMed
    Score: 0.142
  39. Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis. Invest Ophthalmol Vis Sci. 2013 Apr 03; 54(4):2457-64.
    View in: PubMed
    Score: 0.141
  40. Nerves and neovessels inhibit each other in the cornea. Invest Ophthalmol Vis Sci. 2013 Jan 28; 54(1):813-20.
    View in: PubMed
    Score: 0.139
  41. Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Invest Ophthalmol Vis Sci. 2012 Aug 17; 53(9):5632-40.
    View in: PubMed
    Score: 0.135
  42. b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern. Cornea. 2012 Jul; 31(7):804-9.
    View in: PubMed
    Score: 0.133
  43. PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease. Invest Ophthalmol Vis Sci. 2012 Jun 14; 53(7):3584-91.
    View in: PubMed
    Score: 0.133
  44. Efficacy of topical blockade of interleukin-1 in experimental dry eye disease. Am J Ophthalmol. 2012 Jul; 154(1):63-71.
    View in: PubMed
    Score: 0.132
  45. Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis. Invest Ophthalmol Vis Sci. 2012 Mar; 53(3):1244-50.
    View in: PubMed
    Score: 0.130
  46. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012 May; 31(3):271-85.
    View in: PubMed
    Score: 0.130
  47. Dependence of corneal stem/progenitor cells on ocular surface innervation. Invest Ophthalmol Vis Sci. 2012 Feb 21; 53(2):867-72.
    View in: PubMed
    Score: 0.130
  48. Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation. J Leukoc Biol. 2012 Apr; 91(4):621-7.
    View in: PubMed
    Score: 0.130
  49. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012 Jan; 130(1):90-100.
    View in: PubMed
    Score: 0.129
  50. Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. Cornea. 2011 Dec; 30(12):1465-72.
    View in: PubMed
    Score: 0.128
  51. Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease. Arch Ophthalmol. 2012 Jan; 130(1):84-9.
    View in: PubMed
    Score: 0.126
  52. A novel mouse model for neurotrophic keratopathy: trigeminal nerve stereotactic electrolysis through the brain. Invest Ophthalmol Vis Sci. 2011 Apr; 52(5):2532-9.
    View in: PubMed
    Score: 0.123
  53. Effect of topical azithromycin on corneal innate immune responses. Invest Ophthalmol Vis Sci. 2011 Apr 19; 52(5):2525-31.
    View in: PubMed
    Score: 0.123
  54. A novel function for programmed death ligand-1 regulation of angiogenesis. Am J Pathol. 2011 04; 178(4):1922-9.
    View in: PubMed
    Score: 0.122
  55. Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway. Blood. 2011 May 26; 117(21):5762-71.
    View in: PubMed
    Score: 0.122
  56. Interferon-?-secreting NK cells promote induction of dry eye disease. J Leukoc Biol. 2011 Jun; 89(6):965-72.
    View in: PubMed
    Score: 0.122
  57. Thrombospondin-1 derived from APCs regulates their capacity for allosensitization. J Immunol. 2010 Oct 15; 185(8):4691-7.
    View in: PubMed
    Score: 0.118
  58. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? Arch Ophthalmol. 2010 Jul; 128(7):819-24.
    View in: PubMed
    Score: 0.116
  59. Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. Invest Ophthalmol Vis Sci. 2010 May; 51(5):2411-7.
    View in: PubMed
    Score: 0.111
  60. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol. 2009 Nov; 175(5):1984-92.
    View in: PubMed
    Score: 0.110
  61. Role of CCR7 in facilitating direct allosensitization and regulatory T-cell function in high-risk corneal transplantation. Invest Ophthalmol Vis Sci. 2010 Feb; 51(2):816-21.
    View in: PubMed
    Score: 0.110
  62. Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. Arch Ophthalmol. 2009 Jul; 127(7):882-7.
    View in: PubMed
    Score: 0.108
  63. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci. 2009 Oct; 50(10):4743-52.
    View in: PubMed
    Score: 0.107
  64. Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci. 2009 Aug; 50(8):3802-7.
    View in: PubMed
    Score: 0.106
  65. 'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival. Am J Transplant. 2009 Mar; 9(3):473-82.
    View in: PubMed
    Score: 0.106
  66. Depletion of passenger leukocytes from corneal grafts: an effective means of promoting transplant survival? Invest Ophthalmol Vis Sci. 2009 Jul; 50(7):3137-44.
    View in: PubMed
    Score: 0.105
  67. Regulation of blood vessel versus lymphatic vessel growth in the cornea. Invest Ophthalmol Vis Sci. 2009 Apr; 50(4):1613-8.
    View in: PubMed
    Score: 0.104
  68. Change in prostaglandin expression levels and synthesizing activities in dry eye disease. Ophthalmology. 2012 Nov; 119(11):2211-9.
    View in: PubMed
    Score: 0.034
  69. Characterization of Langerin-expressing dendritic cell subsets in the normal cornea. Invest Ophthalmol Vis Sci. 2011 Jun 28; 52(7):4598-604.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.